When to Take Fish Oil: Morning, Night or With Food?

Take fish oil with a meal that contains fat. In one trial, a 44 g fat meal raised absorption of ethyl-ester EPA and DHA three-fold, to about 60%¹. Morning versus night has no proven winner, so choose the fatty meal you eat most reliably.

That advice is about absorption, not outcomes. We found no trial showing that taking fish oil with food, or at a set hour, changes heart, eye or skin results. For what fish oil does and how much to take, see our evidence page.

Take it with food, ideally a meal that contains some fat. Your gut needs bile and digestive enzymes, released when you eat fat, to absorb the omega-3 fats in fish oil^{2, 3}.

The clearest numbers come from a 1988 study in male volunteers. Absorption of EPA and DHA from ethyl-ester fish oil, the form in many concentrated capsules, rose three-fold, to about 60%, with a 44 g fat meal compared with values reported earlier for an 8 g fat meal¹. For natural triglyceride fish oil, EPA absorption rose from 69% to 90%, while DHA absorption did not change significantly¹.

More recent trials point the same way:

• Low-fat versus high-fat periods (54 overweight adults): after single 4 g doses, 3 of 50 people (6.0%) taking an ethyl-ester product kept at least half of their high-fat-period absorption when fat was low, against 30 of 51 (58.8%) taking a free fatty acid form⁴.
• Before, after or without a meal (42 men): a prescription free fatty acid omega-3 gave lower peak and total blood levels when taken fasting or before a meal than after one⁵. Diarrhea was reported by five men in the fasting period and six in the before-meal period, and by none after a meal⁵.
• A self-emulsifying formulation: its developers built an ethyl-ester product to be absorbed without a fatty meal, and it delivered 6.4 to 11.5 times more EPA plus DHA while fasting than a standard ethyl-ester control².

These are single-dose studies of blood levels. A 2025 review found that large differences in acute absorption often did not carry over to long-term supplementation⁶. In a 30-day trial of 60 healthy adults taking six capsules a day, taking them with milk, with food, on an empty stomach or frozen showed no apparent difference in adherence or self-reported side effects in this small open-label pilot, about 15 people per arm⁷.

Mostly not, in healthy adults. A 2016 trial found that the lipid structure (natural triglyceride, re-esterified triglyceride, free fatty acid or ethyl ester) did not change how EPA and DHA entered most blood lipid pools over 6 hours in 9 men, or after 12 weeks of supplementation in 10 men and 10 women per supplement. Two exceptions: EPA entering free fatty acids in blood was lower from ethyl esters, and DHA peaked higher and sooner from free fatty acids in men⁸.

The 2025 review ranks the forms for acute absorption as free fatty acids, then phospholipids, re-esterified triglycerides, natural triglycerides and ethyl esters last⁶. Form matters most when your meals are low in fat, where ethyl esters absorbed worst in the trials above.

There is no proven best hour. Only one small study compared dosing times, and it measured blood fats, not heart, eye or skin outcomes.

• For morning: in an 8-week pilot of 20 healthy Japanese adults, fish oil sausages (1,010 mg DHA and 240 mg EPA) eaten at breakfast lowered serum triglycerides significantly in the morning group, while blood omega-3 levels rose equally whether the fish oil came in the morning or the evening⁹.
• A rhythm, not a dosing trial: in 21 healthy adults sampled every two hours for 24 hours, plasma DHA bottomed out at 05:43 and EPA at 08:41 without supplements. The authors suggested that night-time intake, which counteracts that overnight fall, may have functional significance¹⁰.

Can you take fish oil at night? We found no trial reporting a problem specific to evening dosing. Heartburn is a listed side effect¹¹, and belching was more common with prescription EPA and DHA products¹², so if they bother you after dinner, an earlier meal is a reasonable thing to try, though no trial has tested it.

If sleep is your reason for taking fish oil, the evidence is on our improved sleep quality page.

Mild digestive complaints are the usual cost. NIH lists unpleasant taste, bad breath, heartburn, nausea, stomach discomfort, diarrhea, headache and odoriferous sweat¹¹. A 2023 meta-analysis of 90 randomized trials found higher odds than placebo of altered taste (odds ratio 3.48), diarrhea (1.26) and bleeding tendency (1.26), with no definite serious adverse events¹³.

A meta-analysis of 21 trials of prescription products (24,460 participants) tied EPA and DHA combinations to more belching and nausea¹².

What the trials say about common tricks:

• Freezing capsules or taking them with milk: no apparent difference in side effects or adherence in the small 60-adult, 30-day open-label pilot⁷.
• Taking a dose with a meal: diarrhea appeared only in the fasting and before-meal periods of the 42-man crossover⁵.

If reflux is a wider problem for you, read about heartburn and acid reflux before adding any capsule.

No. Several groups should talk to a clinician first, and timing does not change any of these risks.

• People with atrial fibrillation or high heart risk: fish oil was linked to more atrial fibrillation, and the prescription label warns of more frequent recurrences in people who already have it¹⁴ (next section).
• People taking warfarin or similar anticoagulants: fish oil might prolong clotting time (a higher INR), although most research indicates that 3 to 6 g a day does not significantly change anticoagulant status¹¹. Our guide to blood thinners and supplements covers the wider list. The 90-trial meta-analysis also found higher odds of bleeding tendency¹³. Prescription labels say to monitor INR periodically when taken with an anticoagulant¹¹.
• People with a fish or shellfish allergy: the prescription label says to use caution with known hypersensitivity to fish or shellfish¹⁴.
• People with liver disease: the label advises periodic ALT and AST monitoring in hepatic impairment¹⁴.
• People with high LDL cholesterol: fish oil lowers triglycerides but can raise LDL slightly, so a clinician should set the plan (see below).

The worry is atrial fibrillation (AF), an irregular heart rhythm. A 2021 meta-analysis of 7 trials (81,210 people, mean age 65) found marine omega-3 raised AF risk (hazard ratio 1.25; 95% CI 1.07 to 1.46), with a bigger effect above 1 g a day (1.49) than at 1 g or less (1.12; 95% CI 1.03 to 1.22, also significant)¹⁵.

The largest single trial, VITAL, gave 25,119 adults aged 50 or older 840 mg a day of EPA and DHA. Over a median 5.3 years, AF occurred in 3.7% versus 3.4% on placebo, a difference that was not significant (hazard ratio 1.09; 95% CI 0.96 to 1.24)¹⁶.

A 2026 meta-analysis of 35 trials (114,592 people) found a significant rise only in people at high heart risk taking more than 1,500 mg a day (odds ratio 1.43; absolute risk difference 0.8 percentage points). The other three groups had odds ratios of 1.03 to 1.07, none significant¹⁷. The two meta-analyses disagree about low doses. NIH notes that two large trials of 4 g a day found a slight increase in AF in people with, or at high risk of, cardiovascular disease¹¹.

Cholesterol alone is not a reason to stop. NIH summarizes a 2020 Cochrane review of 86 trials (162,796 participants) that found about 15% lower serum triglycerides and slightly fewer cardiovascular deaths and coronary events with long-chain omega-3s, although the supplements did not affect all-cause mortality, cardiovascular events, stroke or arrhythmia¹¹.

LDL cholesterol is the caveat: in a meta-analysis of prescription products, EPA and DHA combinations raised LDL cholesterol by about 4.1 mg/dL¹², and the prescription label says to monitor LDL periodically¹⁴. Your clinician weighs that against the triglyceride effect. See our pages on omega-3 for high cholesterol and omega-3 for triglyceride reduction, and the heart health hub.

The evidence is weak for both, and no study tested timing for either. In the DREAM trial, 535 people with moderate-to-severe dry eye took 3,000 mg a day of EPA and DHA or an olive oil placebo for 12 months. Symptom scores improved by 13.9 points on fish oil and 12.5 on placebo, a difference of 1.9 points that was not significant (95% CI -5.0 to 1.1)¹⁸.

For skin, a 2020 review of omega-3 and omega-6 fatty acids in inflammatory skin disease called the results mostly opposing and inconclusive¹⁹. Our pages cover the detail: omega-3 for dry eyes, omega-3 for acne and skin hydration.

Use these rules in order:

• Pick a meal that has fat. Eggs at breakfast, a mixed lunch or dinner all work. The 1988 gain came from fat in the meal, 44 g against 8 g, not from the hour¹.
• On low-fat meals, check the form. Ethyl esters absorbed worst when fat was low, and free fatty acid or self-emulsifying forms held up better^{4, 2}. Ask a pharmacist what your product contains.
• If it repeats on you, move it. Try a different meal; freezing and milk showed no apparent benefit⁷.
• If you take warfarin or have a heart rhythm condition, ask your clinician before starting or raising a dose¹¹.
• Dose: follow the dosage guidance on the evidence page, not a time of day.

We searched PubMed through a research index for absorption with meals, time of day, tolerability, atrial fibrillation, dry eye and skin, and read the NIH Office of Dietary Supplements omega-3 fact sheet and the warnings section of a prescription omega-3 label on DailyMed. We read the PubMed record of 17 studies and cited every one, favoring randomized trials and meta-analyses. The absorption trials are single-dose and measure blood levels, we found no trial comparing morning with evening on clinical outcomes, and none tested meal timing for heart, eye or skin results. Researched 30 October 2026.

1. Lawson LD, et al. Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal. Biochem Biophys Res Commun. 1988;156(2):960-3. doi:10.1016/s0006-291x(88)80937-9
2. Qin Y, et al. A novel self-micro-emulsifying delivery system (SMEDS) formulation significantly improves the fasting absorption of EPA and DHA from a single dose of an omega-3 ethyl ester concentrate. Lipids Health Dis. 2017;16(1):204. doi:10.1186/s12944-017-0589-0
3. Schuchardt JP, et al. Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2013;89(1):1-8. doi:10.1016/j.plefa.2013.03.010
4. Davidson MH, et al. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova(®) compared to Lovaza(®) in a pharmacokinetic single-dose evaluation) study. J Clin Lipidol. 2012;6(6):573-84. doi:10.1016/j.jacl.2012.01.002
5. Shimada H, et al. Effects of Food on the Pharmacokinetics of Omega-3-Carboxylic Acids in Healthy Japanese Male Subjects: A Phase I, Randomized, Open-label, Three-period, Crossover Trial. J Atheroscler Thromb. 2017;24(9):980-987. doi:10.5551/jat.38737
6. Alijani S, et al. Bioavailability of EPA and DHA in humans - A comprehensive review. Prog Lipid Res. 2025;97:101318. doi:10.1016/j.plipres.2024.101318
7. Malinowski SS, et al. Effect of fish oil supplement administration method on tolerability and adherence: a randomized pilot clinical trial. Pilot Feasibility Stud. 2019;5:3. doi:10.1186/s40814-018-0387-0
8. West AL, et al. Lipid structure does not modify incorporation of EPA and DHA into blood lipids in healthy adults: a randomised-controlled trial. Br J Nutr. 2016;116(5):788-97. doi:10.1017/S0007114516002713
9. Konishi T, et al. Time-of-day effects of consumption of fish oil-enriched sausages on serum lipid parameters and fatty acid composition in normolipidemic adults: A randomized, double-blind, placebo-controlled, and parallel-group pilot study. Nutrition. 2021;90:111247. doi:10.1016/j.nut.2021.111247
10. Jackson PA, et al. Diurnal rhythm of plasma EPA and DHA in healthy adults. Prostaglandins Leukot Essent Fatty Acids. 2020;154:102054. doi:10.1016/j.plefa.2020.102054
11. National Institutes of Health, Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
12. Chang CH, et al. Safety and tolerability of prescription omega-3 fatty acids: A systematic review and meta-analysis of randomized controlled trials. Prostaglandins Leukot Essent Fatty Acids. 2018;129:1-12. doi:10.1016/j.plefa.2018.01.001
13. Chang JP, et al. Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr. 2023;14(6):1326-1336. doi:10.1016/j.advnut.2023.08.003
14. U.S. National Library of Medicine, DailyMed. Omega-3-acid ethyl esters capsule: prescribing information (FDA-approved label), warnings and precautions. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21cfa4ce-0b05-47ed-b268-339eb1b83b75
15. Gencer B, et al. Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Circulation. 2021;144(25):1981-1990. doi:10.1161/CIRCULATIONAHA.121.055654 Our study summary.
16. Albert CM, et al. Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial. JAMA. 2021;325(11):1061-1073. doi:10.1001/jama.2021.1489
17. Abuknesha NR, et al. Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals. Circ Arrhythm Electrophysiol. 2026;19(8):e014785. doi:10.1161/CIRCEP.125.014785
18. Dry Eye Assessment and Management Study Research Group, et al. n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease. N Engl J Med. 2018;378(18):1681-1690. doi:10.1056/NEJMoa1709691 Our study summary.
19. Balić A, et al. Omega-3 Versus Omega-6 Polyunsaturated Fatty Acids in the Prevention and Treatment of Inflammatory Skin Diseases. Int J Mol Sci. 2020;21(3). doi:10.3390/ijms21030741